These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1038 related items for PubMed ID: 7600653

  • 1. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul 15; 92(2):212-8. PubMed ID: 7600653
    [Abstract] [Full Text] [Related]

  • 2. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb 08; 349(9049):375-80. PubMed ID: 9033462
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR.
    J Am Coll Cardiol; 1995 May 08; 25(6):1225-31. PubMed ID: 7722114
    [Abstract] [Full Text] [Related]

  • 4. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K, Norton GR, Kone N, Candy G, Kachope J, Woodiwiss AJ, Libhaber C, Sareli P, Essop R.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1825-30. PubMed ID: 15519014
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N.
    J Am Coll Cardiol; 1997 Apr 02; 29(5):1060-6. PubMed ID: 9120160
    [Abstract] [Full Text] [Related]

  • 6. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 7. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, MUCHA Investigators.
    Am Heart J; 2004 Feb 27; 147(2):324-30. PubMed ID: 14760332
    [Abstract] [Full Text] [Related]

  • 8. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R, Tarantini G, Boffa GM, Orlando S, Iliceto S.
    Ital Heart J; 2004 Jul 27; 5(7):517-22. PubMed ID: 15487269
    [Abstract] [Full Text] [Related]

  • 9. Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N.
    J Card Fail; 2000 Mar 27; 6(1):11-8. PubMed ID: 10746814
    [Abstract] [Full Text] [Related]

  • 10. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS, Senior R, Soman P, van der Does R, Lahiri A.
    Am Heart J; 2001 Oct 27; 142(4):704-13. PubMed ID: 11579363
    [Abstract] [Full Text] [Related]

  • 11. Effects of carvedilol on left ventricular diastolic function and chamber volumes in advanced heart failure.
    Palazzuoli A, Quatrini I, Vecchiato L, Scali C, De Paola V, Iovine F, Martini G, Nuti R.
    Minerva Cardioangiol; 2005 Aug 27; 53(4):321-8. PubMed ID: 16177676
    [Abstract] [Full Text] [Related]

  • 12. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR.
    Am J Cardiol; 1996 Oct 01; 78(7):779-84. PubMed ID: 8857482
    [Abstract] [Full Text] [Related]

  • 13. Carvedilol produces sustained long-term benefits: follow-up at 12 years.
    MacGregor JF, Wachter SB, Munger M, Stoddard G, Bristow MR, Gilbert EM.
    Congest Heart Fail; 2009 Oct 01; 15(1):5-8. PubMed ID: 19187400
    [Abstract] [Full Text] [Related]

  • 14. Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction.
    Takeda Y, Fukutomi T, Suzuki S, Yamamoto K, Ogata M, Kondo H, Sugiura M, Shigeyama J, Itoh M.
    Am J Cardiol; 2004 Aug 15; 94(4):448-53. PubMed ID: 15325927
    [Abstract] [Full Text] [Related]

  • 15. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E, Kurum T.
    Can J Cardiol; 2005 Mar 15; 21(4):344-8. PubMed ID: 15838561
    [Abstract] [Full Text] [Related]

  • 16. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
    DasGupta P, Broadhurst P, Lahiri A.
    J Cardiovasc Pharmacol; 1991 Mar 15; 18 Suppl 4():S12-6. PubMed ID: 1721973
    [Abstract] [Full Text] [Related]

  • 17. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S, Febo O, Gnemmi M, Riccardi G, Opasich C, Caporotondi A, Mortara A, Pinna GD, Cobelli F.
    Am Heart J; 2000 Apr 15; 139(4):596-608. PubMed ID: 10740140
    [Abstract] [Full Text] [Related]

  • 18. Left ventricular remodelling and improved long-term outcomes in chronic heart failure.
    Sharpe N, Doughty RN.
    Eur Heart J; 1998 Feb 15; 19 Suppl B():B36-9. PubMed ID: 9519350
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy of nebivolol versus carvedilol on left ventricular function and exercise capacity in patients with nonischemic dilated cardiomyopathy. A 12-month study.
    Patrianakos AP, Parthenakis FI, Mavrakis HE, Diakakis GF, Chlouverakis GI, Vardas PE.
    Am Heart J; 2005 Nov 15; 150(5):985. PubMed ID: 16290981
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol.
    Guazzi M, Agostoni P, Matturri M, Pontone G, Guazzi MD.
    Am Heart J; 1999 Sep 15; 138(3 Pt 1):460-7. PubMed ID: 10467196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.